BioCryst Pharmaceuticals, Inc. (BCRX)
8.91
-0.19
(-2.09%)
USD |
NASDAQ |
May 29, 16:00
8.92
+0.01
(+0.11%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Assets (Quarterly) : 465.05M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Dyne Therapeutics, Inc. | 1.080B |
| Taysha Gene Therapies, Inc. | 300.35M |
| Agenus, Inc. | 186.46M |
| Amgen, Inc. | 92.50B |
| Anika Therapeutics, Inc. | 179.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.019B |
| Shareholders Equity (Quarterly) | -553.84M |
| Debt to Equity Ratio | -1.549 |
| Current Ratio | 1.912 |
| Net Debt Paydown Yield | -0.14% |